Corrigendum: Neuroprotective Effects of the Anti-Cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis

Ji-Ning Jia; Xi-Xi Yin; Qin Li; Qi-Wen Guan; Nan Yang; Kang-Ni Chen; Hong-Hao Zhou; Xiao-Yuan Mao

doi:10.3389/fphar.2021.810295

Corrigendum: Neuroprotective Effects of the Anti-Cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis

Front Pharmacol. 2022 Jan 3:12:810295. doi: 10.3389/fphar.2021.810295. eCollection 2021.

Authors

Ji-Ning Jia^{1

2

3

4}, Xi-Xi Yin⁵, Qin Li^{1

2

3

4}, Qi-Wen Guan^{1

2

3

4}, Nan Yang^{1

2

3

4}, Kang-Ni Chen^{1

2

3

4}, Hong-Hao Zhou^{1

2

3

4}, Xiao-Yuan Mao^{1

2

3

4}

Affiliations

¹ Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
² Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China.
³ Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China.
⁴ National Clinical Research Center for Geriatric Disorders, Changsha, China.
⁵ Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.601572.].

Keywords: epileptic seizures; ferroptosis; glutathione peroxidase 4; lapatinib; lipid peroxidation; neuroprotection.

Publication types

Published Erratum